Liquidia Corporation (LQDA) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $45.08 (+0.20%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 13, 2026 | Amy Li | Jefferies | $55.00 | +22.0% |
| Nov 4, 2025 | Ryan Deschner | Raymond James | $47.00 | +4.3% |
| May 19, 2025 | Andreas Argyrides | Oppenheimer | $13.00 | -71.2% |
| May 5, 2025 | Greg Harrison | Scotiabank | $36.00 | -20.1% |
| Mar 20, 2025 | Greg Harrison | Scotiabank | $34.00 | -24.6% |
| Jan 9, 2025 | Serge Belanger | Needham | $19.00 | -57.9% |
| Aug 20, 2024 | Jason Gerberry | Bank of America Securities | $23.00 | -49.0% |
| Aug 19, 2024 | Kambiz Yazdi | Jefferies | $17.00 | -62.3% |
| Aug 19, 2024 | Strong Buy | Raymond James | $27.00 | -40.1% |
| May 14, 2024 | Kambiz Yazdi | Jefferies | $23.00 | -49.0% |
| Sep 1, 2022 | Liana Moussatos | Wedbush | $3.00 | -93.3% |
Top Analysts Covering LQDA
LQDA vs Sector & Market
| Metric | LQDA | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.26 | 2.25 | 2.41 |
| Analyst Count | 23 | 8 | 19 |
| Target Upside | +60.5% | +153002.0% | +21.5% |
| P/E Ratio | 324.08 | 3.17 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $145M | $177M | $206M | 2 |
| 2027-03-31 | $239M | $290M | $339M | 2 |
| 2027-06-30 | $268M | $326M | $380M | 2 |
| 2027-09-30 | $289M | $351M | $410M | 2 |
| 2027-12-31 | $324M | $394M | $460M | 2 |
| 2028-12-31 | $1.13B | $1.13B | $1.13B | 6 |
| 2029-12-31 | $853M | $1.27B | $1.64B | 5 |
| 2030-12-31 | $924M | $1.38B | $1.78B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.68 | $0.88 | $1.07 | 2 |
| 2027-03-31 | $1.12 | $1.46 | $1.78 | 2 |
| 2027-06-30 | $1.29 | $1.68 | $2.05 | 1 |
| 2027-09-30 | $1.45 | $1.89 | $2.30 | 1 |
| 2027-12-31 | $1.19 | $1.54 | $1.88 | 2 |
| 2028-12-31 | $0.44 | $5.41 | $8.94 | 6 |
| 2029-12-31 | $3.36 | $5.87 | $8.10 | 4 |
| 2030-12-31 | $3.54 | $6.17 | $8.52 | 2 |
Frequently Asked Questions
What is the analyst consensus for LQDA?
The consensus among 23 analysts covering Liquidia Corporation (LQDA) is Buy with an average price target of $98.11.
What is the highest price target for LQDA?
The highest price target for LQDA is $55.00, set by Amy Li at Jefferies on 2026-01-13.
What is the lowest price target for LQDA?
The lowest price target for LQDA is $3.00, set by Liana Moussatos at Wedbush on 2022-09-01.
How many analysts cover LQDA?
23 analysts have issued ratings for Liquidia Corporation in the past 12 months.
Is LQDA a buy or sell right now?
Based on 23 analyst ratings, LQDA has a consensus rating of Buy (2.26/5) with a +60.5% upside to the consensus target of $98.11.
What are the earnings estimates for LQDA?
Analysts estimate LQDA will report EPS of $0.88 for the period ending 2026-12-31, with revenue estimated at $177M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.